Silva, VanessaAlmeida, FranciscoSilva, AdrianaCorreia, SusanaCarvalho, José AntónioCastro, Ana PaulaFerreira, EugéniaManageiro, VeraCaniça, ManuelaIgrejas, GilbertoPoeta, Patrícia2020-04-242020-04-242019-05-22J Glob Antimicrob Resist . 2019 Jun;17:323-325. doi: 10.1016/j.jgar.2019.05.017. Epub 2019 May 222213-7165http://hdl.handle.net/10400.18/6505Letter to the EditorLinezolid and vancomycin are the most reliable therapeutic agents to treat complicated soft tissue infections caused by multidrug-resistant methicillin-resistant Staphylococcus aureus (MRSA) strains. However, despite the fact that the prevalence of linezolid-resistant MRSA strains (LR-MRSA) remains overall low, in the past few years resistance to linezolid has been reported among human patients worldwide, imposing a public-health concern, in particular when associated with a mobile gene such as cfr [1]. The aim of this study was to identify LR-MRSA isolates recovered from infected diabetic foot ulcers and to characterise their antimicrobial resistance profiles and genetic lineage. (...)engLinezolidLR-MRSAcfrPortugalResistência aos AntimicrobianosFirst report of linezolid-resistant cfr-positive methicillin-resistant Staphylococcus aureus in humans in Portugaljournal article10.1016/j.jgar.2019.05.017